Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?
No abstract is available for this record.
Bibliographic context
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.Unknown journal · 2024-07-19Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.Unknown journal · 2024-05-22Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.Unknown journal · 2024-03-27An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-12Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-14Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depressionPsychedelics. · 2024-08-11Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexiaPsychedelics. · 2026-02-02